Recombinant Escherichia coli O6:K15:H31 Fumarate reductase subunit D (frdD)

Basic Research Questions

• What is the structural and functional role of Fumarate reductase subunit D (frdD) in E. coli O6:K15:H31?

Fumarate reductase subunit D (frdD) is a critical component of the membrane-bound fumarate reductase complex in E. coli O6:K15:H31 (strain 536), which functions in anaerobic respiration. This 13 kDa hydrophobic protein contains 119 amino acids and serves as one of the membrane anchor subunits of the FrdABCD complex. The FrdABCD complex catalyzes the reduction of fumarate to succinate, allowing E. coli to utilize fumarate as a terminal electron acceptor during anaerobic growth when oxygen and nitrate are unavailable .

Structurally, frdD works alongside frdC as an anchor subunit, attaching the catalytic subunit (FrdA) and the iron-sulfur subunit (FrdB) to the cell membrane. The membrane-anchoring function is critical for positioning the enzyme within the cell's respiratory chain. FrdC and FrdD accept electrons from quinols (specifically menaquinol in E. coli) and transfer them to FrdB, which then transfers them to FrdA, where fumarate is reduced to succinate .

• How is the expression of the frdABCD operon regulated in E. coli O6:K15:H31?

The expression of the frdABCD operon in E. coli O6:K15:H31 is tightly regulated at the transcriptional level in response to environmental conditions, particularly the availability of terminal electron acceptors:

• Oxygen regulation: Expression increases approximately 10-fold during anaerobic growth compared to aerobic conditions .

• Fumarate induction: The presence of fumarate, the substrate, increases expression by an additional 1.5-fold .

• Nitrate repression: Nitrate, a preferred electron acceptor, decreases expression by about 23-fold .

This regulation involves several molecular mechanisms:

• FNR protein: The FNR (fumarate and nitrate reduction) regulatory protein is primarily responsible for anaerobic activation of frd operon expression. In fnr mutants, anaerobic induction is impaired and can be restored when the fnr+ gene is provided in trans .

• Transcriptional control: The frd mRNA transcript initiates with an adenine residue 93 bases prior to the start of frdA translation and terminates in a uridine-rich region centered at 46 bases after the last codon of frdD .

• Termination structure: A stem and loop structure serves the dual role of an frd terminator under anaerobic conditions and an ampC attenuator under aerobic conditions .

• What are the biochemical characteristics of fumarate reductase activity in E. coli?

Fumarate reductase in E. coli exhibits specific biochemical properties that are important for researchers to consider:

• Reaction catalyzed: FRD reduces fumarate to succinate using two electrons, typically supplied by quinol, FADH2/FMNH2, or NADH .

• Enzyme kinetics: Standard assay conditions for measuring FRD activity include:

  • Buffer: 50 mM NaPO4 (pH 6.5)

  • Substrate: 20 mM fumarate

  • Electron donor: 0.2 mM NADH

  • Temperature: Often performed at 70°C under anaerobic (Ar gas) conditions

  • Measurement: Decrease in NADH monitored at 340 nm

• Km values: For accurate kinetic analysis, researchers typically test:

  • Fumarate concentrations: 0.01 to 20 mM

  • NADH concentrations: 0.03 to 0.2 mM

• Alternative electron donors: The enzyme can also accept electrons from:

  • FADH2 (0.25 mM FAD reduced with dithionite)

  • FMNH2 (0.25 mM FMN reduced with dithionite)

  • Reduced methyl viologen (5 mM MV)

  • Reduced benzyl viologen (10 mM BV)

• How does the FrdD subunit contribute to quinone binding in the fumarate reductase complex?

The FrdD subunit plays a crucial role in defining the proximal menaquinol (MQH2) binding site (QP) of E. coli fumarate reductase. Based on fluorescence quench (FQ) titrations and site-directed mutagenesis studies:

• FrdD contributes to forming the quinone binding pocket along with FrdB and FrdC .

• The H80 residue in FrdD is particularly important for quinone binding; the FrdD-H80K mutation significantly increases the apparent Kd value for HOQNO (a menaquinol analog) from 2.5 nm to 20 nm .

• The QP site is the sole high-affinity quinone binding site in the FrdABCD complex, as evidenced by monophasic binding in fluorescence quench titrations .

• Mutations affecting HOQNO binding generally correlate with effects on the observed Km and kcat values for fumarate-dependent quinol oxidation, highlighting the functional importance of proper quinone binding for enzyme activity .

Advanced Research Questions

• What methodologies are effective for heterologous expression of recombinant E. coli O6:K15:H31 frdD?

For effective heterologous expression of recombinant E. coli O6:K15:H31 frdD, several methodological considerations are critical:

Expression system optimization:

• Promoter selection: T7 expression systems with arabinose-inducible promoters (PBAD) show lower insoluble protein fractions compared to trc or tac promoters, which is crucial for membrane proteins like frdD .

• Induction conditions: Using lower inducer concentrations (0.015% arabinose instead of 0.2%) with glucose as carbon source provides finer control over expression levels, helping prevent protein aggregation .

• Carbon source: Glycerol as a carbon source typically yields higher protein expression levels compared to glucose, but glucose can help "dampen" expression when precise control is needed .

Monitoring and validation approaches:

• Flow cytometry (FCM): Can be used to rapidly assess protein expression by fusing GFP to frdD. This method correlates well with soluble protein content determined by SDS-PAGE but is much faster (5-10 minutes versus hours) .

• Solubility assessment: Determine soluble/insoluble fractions through SDS-PAGE and densitometric analysis. For membrane proteins like frdD, detergent screening is essential for extraction and maintaining native conformation .

• Fluorescence quench titrations: Can be used to confirm proper folding and function of frdD by assessing binding of quinone analogs like HOQNO .

Temperature and expression kinetics:

• Growth at lower temperatures (typically 25-30°C versus 37°C) allows slower protein production, improving membrane insertion and proper folding of hydrophobic proteins like frdD .

• Extended induction times at lower temperatures may yield better results than short, high-intensity expression.

• How can site-directed mutagenesis be applied to study the functional domains of frdD in fumarate reductase activity?

Site-directed mutagenesis is a powerful approach for understanding the structure-function relationship of frdD in the fumarate reductase complex:

Key residues for mutation studies:

• FrdD-H80: Mutation to lysine (FrdD-H80K) significantly impacts quinone binding, as shown by increasing the apparent Kd for HOQNO from 2.5 nm to 20 nm. This residue is critical for proper interaction with the quinone substrate .

• Transmembrane helices: The hydrophobic regions that anchor the protein in the membrane can be systematically mutated to determine their role in membrane insertion and complex assembly.

• Interface residues: Amino acids at the interface with other subunits (particularly FrdC) can be mutated to study subunit interactions.

Methodological approach:

• Primer design: Design overlapping primers containing the desired mutation following standard protocols for site-directed mutagenesis.

• PCR amplification: Use high-fidelity polymerase to minimize unwanted mutations.

• DpnI digestion: To remove methylated template DNA.

• Transformation: Into competent E. coli cells.

• Sequence verification: Confirm successful mutagenesis.

Functional analyses of mutants:

• Fluorescence quench titrations: To measure quinone binding affinity (Kd) of the mutant protein .

• EPR spectroscopy: To detect bound menasemiquinone radicals and assess electron transfer capability .

• Steady-state kinetics: Measure fumarate-dependent quinol oxidation to determine Km and kcat values of the mutant proteins .

• Membrane potential measurements: To assess the impact of mutations on proton translocation.

• What approaches can be used to investigate the role of frdD in electron transfer within the fumarate reductase complex?

Investigating the role of frdD in electron transfer requires sophisticated biophysical and biochemical approaches:

Spectroscopic techniques:

• EPR spectroscopy: Essential for detecting and characterizing paramagnetic species such as menasemiquinone radicals formed during electron transfer. EPR can detect when electrons are trapped at specific sites in the electron transport chain, such as the case with the FrdC-E29L mutant where only one electron is removed from menaquinol, resulting in a trapped menasemiquinone radical anion .

• Fluorescence spectroscopy: Using fluorescence quench titrations with quinone analogs like HOQNO to measure binding affinity and assess the integrity of the quinone binding site .

Electrochemical approaches:

• Bioelectrochemical reactors: Systems where electrons can be delivered directly to cells from a cathode. These have shown that the Mtr pathway can deliver cathodic electrons via native fumarate reductases to fumarate, with FrdABCD being responsible for approximately 60% of the current consumption .

• Cyclic voltammetry: To determine the redox potential of the fumarate reductase complex and its components. The catalytic wave for fumarate reduction starts at approximately -43 mV vs. Ag/AgCl, close to the redox potential of FrdAB .

Genetic manipulation:

• Knockout studies: Comparing current consumption by wild-type, ΔfrdABCD, and ΔfrdABCDΔsdhABCD strains has shown that cathodic-derived electrons pass solely through FrdABCD and SdhABCD upon fumarate addition .

• Complementation experiments: Restoring frdD expression in knockout strains to confirm its role in electron transfer.

• How does the expression of frdD change under different pathophysiological conditions in uropathogenic E. coli O6:K15:H31?

The expression of frdD in uropathogenic E. coli O6:K15:H31 (strain 536) varies significantly under different pathophysiological conditions:

Oxygen availability:

• Under anaerobic conditions (such as those found in certain urinary tract infections), frdABCD expression increases approximately 10-fold compared to aerobic conditions .

• This anaerobic induction is mediated by the FNR protein, which acts as a transcriptional activator .

Electron acceptor availability:

• Fumarate presence increases frdABCD expression by an additional 1.5-fold .

• Nitrate, a preferred electron acceptor, decreases expression by about 23-fold .

• This regulation ensures energy efficiency by prioritizing the use of higher-energy-yielding electron acceptors.

Virulence context:

Methodologies for studying expression changes:

• qRT-PCR: For measuring transcript levels of frdD under different conditions.

• Western blotting: To quantify protein levels using antibodies against frdD.

• Reporter gene fusions: Similar to the frdA'-'lacZ fusions used to study promoter activity under different growth conditions .

• RNA-seq: For genome-wide transcriptional profiling to place frdD expression in broader context.

• Proteomics: To study protein abundance changes at a global level.

• What are the current challenges and solutions in purifying functional recombinant frdD for structural studies?

Purifying functional recombinant frdD presents several challenges due to its hydrophobic nature and integration within a multi-subunit complex:

Current challenges:

• Membrane protein solubilization: As a hydrophobic membrane protein, frdD is difficult to extract from membranes while maintaining its native structure.

• Maintaining complex integrity: frdD functions as part of the FrdABCD complex, and isolating it may disrupt important structural features.

• Inclusion body formation: Overexpression often leads to inclusion body formation, especially at higher inducer concentrations and temperatures .

• Proper folding: Ensuring correct folding of membrane proteins in recombinant systems is difficult.

Methodological solutions:

• Co-expression strategies: Express all four subunits (FrdABCD) simultaneously to promote proper complex assembly.

• Detergent screening: Systematic testing of different detergents for optimal solubilization:

  • Mild detergents like n-dodecyl-β-D-maltoside (DDM)

  • Lipid-like detergents such as LMNG

  • Detergent mixtures or amphipols for stabilization

• Expression optimization:

  • Lower growth temperature (25-30°C)

  • Reduced inducer concentration (e.g., 0.015% arabinose instead of 0.2%)

  • Use of specialized expression hosts like C43(DE3), which are better suited for membrane protein expression

• Purification approaches:

  • Affinity tags: His-tags or other fusion tags for initial capture

  • Size-exclusion chromatography: To separate properly assembled complexes from aggregates

  • Ligand-based approaches: Using immobilized quinone analogs to select for functional protein

• Quality assessment:

  • Fluorescence quench titrations with HOQNO to verify quinone binding function

  • EPR spectroscopy to confirm electron transfer capability

  • Activity assays measuring fumarate reduction with appropriate electron donors

• How do the biochemical properties of E. coli O6:K15:H31 fumarate reductase compare with those from other bacterial species?

The biochemical properties of E. coli O6:K15:H31 fumarate reductase differ significantly from those in other bacterial species, with important implications for research:

Structural organization comparison:

Functional differences:

• Oxygen reactivity: Unlike E. coli fumarate reductase, which can produce reactive oxygen species (ROS) when exposed to oxygen, B. thetaiotaomicron fumarate reductase does not react with oxygen at all - neither superoxide nor hydrogen peroxide is formed .

• Electron donors: While E. coli fumarate reductase primarily uses menaquinol as an electron donor, other bacterial species may use different electron sources:

  • NADH-dependent fumarate reductases in some species

  • Coenzyme M and coenzyme B in methanogens

• Kinetic properties: The Km values for fumarate and electron donors vary significantly between species, requiring different assay conditions.

Methodological implications:

• Expression systems: Different bacterial FRDs may require species-specific expression optimizations:

  • Codon optimization

  • Different chaperone co-expression

  • Variable temperature and inducer conditions

• Protein purification: The purification protocol used for E. coli FrdABCD (involving butyl-Toyopearl, DEAE-Toyopearl, hydroxyapatite, MonoQ, and Phenyl Superose chromatography steps) may require modification for other species' enzymes .

• Activity assays: Different spectrophotometric methods may be needed depending on the preferred electron donor:

  • NADH oxidation (340 nm) for NADH-dependent FRDs

  • Succinate production (measured by HPLC) for other types

• ROS production assessment: When working with FRDs from different species, researchers should evaluate oxygen sensitivity and ROS production, as these properties can vary dramatically and affect experimental design .

Frequently Asked Questions: Recombinant Escherichia coli O6:K15:H31 Fumarate Reductase Subunit D (frdD)

Basic Research Questions

• What is the structural and functional role of Fumarate reductase subunit D (frdD) in E. coli O6:K15:H31?

Fumarate reductase subunit D (frdD) is a critical component of the membrane-bound fumarate reductase complex in E. coli O6:K15:H31 (strain 536), which functions in anaerobic respiration. This 13 kDa hydrophobic protein contains 119 amino acids and serves as one of the membrane anchor subunits of the FrdABCD complex. The FrdABCD complex catalyzes the reduction of fumarate to succinate, allowing E. coli to utilize fumarate as a terminal electron acceptor during anaerobic growth when oxygen and nitrate are unavailable .

Structurally, frdD works alongside frdC as an anchor subunit, attaching the catalytic subunit (FrdA) and the iron-sulfur subunit (FrdB) to the cell membrane. The membrane-anchoring function is critical for positioning the enzyme within the cell's respiratory chain. FrdC and FrdD accept electrons from quinols (specifically menaquinol in E. coli) and transfer them to FrdB, which then transfers them to FrdA, where fumarate is reduced to succinate .

• How is the expression of the frdABCD operon regulated in E. coli O6:K15:H31?

The expression of the frdABCD operon in E. coli O6:K15:H31 is tightly regulated at the transcriptional level in response to environmental conditions, particularly the availability of terminal electron acceptors:

• Oxygen regulation: Expression increases approximately 10-fold during anaerobic growth compared to aerobic conditions .

• Fumarate induction: The presence of fumarate, the substrate, increases expression by an additional 1.5-fold .

• Nitrate repression: Nitrate, a preferred electron acceptor, decreases expression by about 23-fold .

This regulation involves several molecular mechanisms:

• FNR protein: The FNR (fumarate and nitrate reduction) regulatory protein is primarily responsible for anaerobic activation of frd operon expression. In fnr mutants, anaerobic induction is impaired and can be restored when the fnr+ gene is provided in trans .

• Transcriptional control: The frd mRNA transcript initiates with an adenine residue 93 bases prior to the start of frdA translation and terminates in a uridine-rich region centered at 46 bases after the last codon of frdD .

• Termination structure: A stem and loop structure serves the dual role of an frd terminator under anaerobic conditions and an ampC attenuator under aerobic conditions .

• What are the biochemical characteristics of fumarate reductase activity in E. coli?

Fumarate reductase in E. coli exhibits specific biochemical properties that are important for researchers to consider:

• Reaction catalyzed: FRD reduces fumarate to succinate using two electrons, typically supplied by quinol, FADH2/FMNH2, or NADH .

• Enzyme kinetics: Standard assay conditions for measuring FRD activity include:

  • Buffer: 50 mM NaPO4 (pH 6.5)

  • Substrate: 20 mM fumarate

  • Electron donor: 0.2 mM NADH

  • Temperature: Often performed at 70°C under anaerobic (Ar gas) conditions

  • Measurement: Decrease in NADH monitored at 340 nm

• Km values: For accurate kinetic analysis, researchers typically test:

  • Fumarate concentrations: 0.01 to 20 mM

  • NADH concentrations: 0.03 to 0.2 mM

• Alternative electron donors: The enzyme can also accept electrons from:

  • FADH2 (0.25 mM FAD reduced with dithionite)

  • FMNH2 (0.25 mM FMN reduced with dithionite)

  • Reduced methyl viologen (5 mM MV)

  • Reduced benzyl viologen (10 mM BV)

• How does the FrdD subunit contribute to quinone binding in the fumarate reductase complex?

The FrdD subunit plays a crucial role in defining the proximal menaquinol (MQH2) binding site (QP) of E. coli fumarate reductase. Based on fluorescence quench (FQ) titrations and site-directed mutagenesis studies:

• FrdD contributes to forming the quinone binding pocket along with FrdB and FrdC .

• The H80 residue in FrdD is particularly important for quinone binding; the FrdD-H80K mutation significantly increases the apparent Kd value for HOQNO (a menaquinol analog) from 2.5 nm to 20 nm .

• The QP site is the sole high-affinity quinone binding site in the FrdABCD complex, as evidenced by monophasic binding in fluorescence quench titrations .

• Mutations affecting HOQNO binding generally correlate with effects on the observed Km and kcat values for fumarate-dependent quinol oxidation, highlighting the functional importance of proper quinone binding for enzyme activity .

Advanced Research Questions

• What methodologies are effective for heterologous expression of recombinant E. coli O6:K15:H31 frdD?

For effective heterologous expression of recombinant E. coli O6:K15:H31 frdD, several methodological considerations are critical:

Expression system optimization:

• Promoter selection: T7 expression systems with arabinose-inducible promoters (PBAD) show lower insoluble protein fractions compared to trc or tac promoters, which is crucial for membrane proteins like frdD .

• Induction conditions: Using lower inducer concentrations (0.015% arabinose instead of 0.2%) with glucose as carbon source provides finer control over expression levels, helping prevent protein aggregation .

• Carbon source: Glycerol as a carbon source typically yields higher protein expression levels compared to glucose, but glucose can help "dampen" expression when precise control is needed .

Monitoring and validation approaches:

• Flow cytometry (FCM): Can be used to rapidly assess protein expression by fusing GFP to frdD. This method correlates well with soluble protein content determined by SDS-PAGE but is much faster (5-10 minutes versus hours) .

• Solubility assessment: Determine soluble/insoluble fractions through SDS-PAGE and densitometric analysis. For membrane proteins like frdD, detergent screening is essential for extraction and maintaining native conformation .

• Fluorescence quench titrations: Can be used to confirm proper folding and function of frdD by assessing binding of quinone analogs like HOQNO .

Temperature and expression kinetics:

• Growth at lower temperatures (typically 25-30°C versus 37°C) allows slower protein production, improving membrane insertion and proper folding of hydrophobic proteins like frdD .

• Extended induction times at lower temperatures may yield better results than short, high-intensity expression.

• How can site-directed mutagenesis be applied to study the functional domains of frdD in fumarate reductase activity?

Site-directed mutagenesis is a powerful approach for understanding the structure-function relationship of frdD in the fumarate reductase complex:

Key residues for mutation studies:

• FrdD-H80: Mutation to lysine (FrdD-H80K) significantly impacts quinone binding, as shown by increasing the apparent Kd for HOQNO from 2.5 nm to 20 nm. This residue is critical for proper interaction with the quinone substrate .

• Transmembrane helices: The hydrophobic regions that anchor the protein in the membrane can be systematically mutated to determine their role in membrane insertion and complex assembly.

• Interface residues: Amino acids at the interface with other subunits (particularly FrdC) can be mutated to study subunit interactions.

Methodological approach:

• Primer design: Design overlapping primers containing the desired mutation following standard protocols for site-directed mutagenesis.

• PCR amplification: Use high-fidelity polymerase to minimize unwanted mutations.

• DpnI digestion: To remove methylated template DNA.

• Transformation: Into competent E. coli cells.

• Sequence verification: Confirm successful mutagenesis.

Functional analyses of mutants:

• Fluorescence quench titrations: To measure quinone binding affinity (Kd) of the mutant protein .

• EPR spectroscopy: To detect bound menasemiquinone radicals and assess electron transfer capability .

• Steady-state kinetics: Measure fumarate-dependent quinol oxidation to determine Km and kcat values of the mutant proteins .

• Membrane potential measurements: To assess the impact of mutations on proton translocation.

• What approaches can be used to investigate the role of frdD in electron transfer within the fumarate reductase complex?

Investigating the role of frdD in electron transfer requires sophisticated biophysical and biochemical approaches:

Spectroscopic techniques:

• EPR spectroscopy: Essential for detecting and characterizing paramagnetic species such as menasemiquinone radicals formed during electron transfer. EPR can detect when electrons are trapped at specific sites in the electron transport chain, such as the case with the FrdC-E29L mutant where only one electron is removed from menaquinol, resulting in a trapped menasemiquinone radical anion .

• Fluorescence spectroscopy: Using fluorescence quench titrations with quinone analogs like HOQNO to measure binding affinity and assess the integrity of the quinone binding site .

Electrochemical approaches:

• Bioelectrochemical reactors: Systems where electrons can be delivered directly to cells from a cathode. These have shown that the Mtr pathway can deliver cathodic electrons via native fumarate reductases to fumarate, with FrdABCD being responsible for approximately 60% of the current consumption .

• Cyclic voltammetry: To determine the redox potential of the fumarate reductase complex and its components. The catalytic wave for fumarate reduction starts at approximately -43 mV vs. Ag/AgCl, close to the redox potential of FrdAB .

Genetic manipulation:

• Knockout studies: Comparing current consumption by wild-type, ΔfrdABCD, and ΔfrdABCDΔsdhABCD strains has shown that cathodic-derived electrons pass solely through FrdABCD and SdhABCD upon fumarate addition .

• Complementation experiments: Restoring frdD expression in knockout strains to confirm its role in electron transfer.

• How does the expression of frdD change under different pathophysiological conditions in uropathogenic E. coli O6:K15:H31?

The expression of frdD in uropathogenic E. coli O6:K15:H31 (strain 536) varies significantly under different pathophysiological conditions:

Oxygen availability:

• Under anaerobic conditions (such as those found in certain urinary tract infections), frdABCD expression increases approximately 10-fold compared to aerobic conditions .

• This anaerobic induction is mediated by the FNR protein, which acts as a transcriptional activator .

Electron acceptor availability:

• Fumarate presence increases frdABCD expression by an additional 1.5-fold .

• Nitrate, a preferred electron acceptor, decreases expression by about 23-fold .

• This regulation ensures energy efficiency by prioritizing the use of higher-energy-yielding electron acceptors.

Virulence context:

Methodologies for studying expression changes:

• qRT-PCR: For measuring transcript levels of frdD under different conditions.

• Western blotting: To quantify protein levels using antibodies against frdD.

• Reporter gene fusions: Similar to the frdA'-'lacZ fusions used to study promoter activity under different growth conditions .

• RNA-seq: For genome-wide transcriptional profiling to place frdD expression in broader context.

• Proteomics: To study protein abundance changes at a global level.

• What are the current challenges and solutions in purifying functional recombinant frdD for structural studies?

Purifying functional recombinant frdD presents several challenges due to its hydrophobic nature and integration within a multi-subunit complex:

Current challenges:

• Membrane protein solubilization: As a hydrophobic membrane protein, frdD is difficult to extract from membranes while maintaining its native structure.

• Maintaining complex integrity: frdD functions as part of the FrdABCD complex, and isolating it may disrupt important structural features.

• Inclusion body formation: Overexpression often leads to inclusion body formation, especially at higher inducer concentrations and temperatures .

• Proper folding: Ensuring correct folding of membrane proteins in recombinant systems is difficult.

Methodological solutions:

• Co-expression strategies: Express all four subunits (FrdABCD) simultaneously to promote proper complex assembly.

• Detergent screening: Systematic testing of different detergents for optimal solubilization:

  • Mild detergents like n-dodecyl-β-D-maltoside (DDM)

  • Lipid-like detergents such as LMNG

  • Detergent mixtures or amphipols for stabilization

• Expression optimization:

  • Lower growth temperature (25-30°C)

  • Reduced inducer concentration (e.g., 0.015% arabinose instead of 0.2%)

  • Use of specialized expression hosts like C43(DE3), which are better suited for membrane protein expression

• Purification approaches:

  • Affinity tags: His-tags or other fusion tags for initial capture

  • Size-exclusion chromatography: To separate properly assembled complexes from aggregates

  • Ligand-based approaches: Using immobilized quinone analogs to select for functional protein

• Quality assessment:

  • Fluorescence quench titrations with HOQNO to verify quinone binding function

  • EPR spectroscopy to confirm electron transfer capability

  • Activity assays measuring fumarate reduction with appropriate electron donors

• How do the biochemical properties of E. coli O6:K15:H31 fumarate reductase compare with those from other bacterial species?

The biochemical properties of E. coli O6:K15:H31 fumarate reductase differ significantly from those in other bacterial species, with important implications for research:

Structural organization comparison:

Functional differences:

• Oxygen reactivity: Unlike E. coli fumarate reductase, which can produce reactive oxygen species (ROS) when exposed to oxygen, B. thetaiotaomicron fumarate reductase does not react with oxygen at all - neither superoxide nor hydrogen peroxide is formed .

• Electron donors: While E. coli fumarate reductase primarily uses menaquinol as an electron donor, other bacterial species may use different electron sources:

  • NADH-dependent fumarate reductases in some species

  • Coenzyme M and coenzyme B in methanogens

• Kinetic properties: The Km values for fumarate and electron donors vary significantly between species, requiring different assay conditions.

Methodological implications:

• Expression systems: Different bacterial FRDs may require species-specific expression optimizations:

  • Codon optimization

  • Different chaperone co-expression

  • Variable temperature and inducer conditions

• Protein purification: The purification protocol used for E. coli FrdABCD (involving butyl-Toyopearl, DEAE-Toyopearl, hydroxyapatite, MonoQ, and Phenyl Superose chromatography steps) may require modification for other species' enzymes .

• Activity assays: Different spectrophotometric methods may be needed depending on the preferred electron donor:

  • NADH oxidation (340 nm) for NADH-dependent FRDs

  • Succinate production (measured by HPLC) for other types

• ROS production assessment: When working with FRDs from different species, researchers should evaluate oxygen sensitivity and ROS production, as these properties can vary dramatically and affect experimental design .